RxDoctor Payments Data

John Young, MD

Orthopedic Surgery · Birmingham, ALNPI 1457392045

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 51.7% of the total. Reporting peaked in 2019 at $448 and has fallen 67.1% since, to $147 in 2025.

$902in general payments, 2019–2025

Across 16 payments — averaging $56.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$466
  • Orthalign Inc$147
  • Johnson & Johnson$80
  • Stryker$80
  • Dynasplint Systems Inc.$47
  • Sanofi-aventis U.S. LLC$37
  • plus $45 from 2 others

What the payments were for

  • Food & beverage$902100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew5$466
Orthalign Inc1$147
Johnson & Johnson(2 entities)4$80
Stryker1$80
Dynasplint Systems Inc.1$47
Sanofi-aventis U.S. LLC2$37
Exactech, Inc.1$27
Heraeus Medical, LLC.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopedic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$206,200
Medicare patients
368
Services billed
9,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen442$2,761
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen348$2,289
Methylprednisolone226$2,143
Meloxicam217$850
Diclofenac Sodium16$601
Methocarbamol74$406
Gabapentin50$197
Tramadol Hcl60$194
Cyclobenzaprine Hcl27$83
Tizanidine Hcl13$81
Amoxicillin18$19

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →